1. FRI0513 Validating Mri-Detected Inflammation Thresholds Predictive of Structural Damage Progression in Patients with Rheumatoid Arthritis in A Randomized Placebo-Controlled Trial. (15th July 2016) Authors: Ahmad, H.A.; Baker, J.F.; Østergaard, M.; Ye, J.; Emery, P.; Conaghan, P.G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0001 Effect of Secukinumab, An Interleukin-17a Inhibitor, on Spinal Radiographic Changes through 2 Years in Patients with Active Ankylosing Spondylitis: Results of The Phase 3 Study, Measure 1. (15th July 2016) Authors: Braun, J.; Baraliakos, X.; Deodhar, A.; Baeten, D.; Sieper, J.; Emery, P.; Talloczy, Z.; Martin, R.; Richards, H.B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0130 Efficacy of A Comprehensive Cardiovascular Risk Reduction Patient Education Programme in Patients with Early Inflammatory Arthritis Following A Treat To Target Therapeutic Regime. (15th July 2016) Authors: Inomata, H.; Bissell, L.-A.; Naraghi, K.; Nam, J.; Burska, A.; Hensor, E.; Emery, P.; Buch, M.; Andrews, J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0171 Serum IL-33 Independently Predicts Response To Rituximab in Rheumatoid Arthritis: Data from The Smart and Replication Cohorts. (15th July 2016) Authors: Sellam, J.; Rivière, E.; Courties, A.; Rouzaire, P.-O.; Tolusso, B.; Vital, E.; Emery, P.; Ferraciolli, G.; Soubrier, M.; Dougados, M.; Mariette, X. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0308 Surface Tetherin Is A Novel Cell-Specific Biomarker for Interferon Response in Systemic Lupus Erythematosus. (15th July 2016) Authors: El-Sherbiny, Y.; Md Yusof, M.Y.; Hensor, E.; Wittmann, M.; Emery, P.; Vital, E. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 546 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0202 Long-Lived CD19-Negative Human Plasma Cells Are Generated at The Plasmablast To Plasma Cell Transition. (15th July 2016) Authors: Arumugakani, G.; Stephenson, S.; Doody, G.; Rawstron, A.C.; Emery, P.; McGonagle, D.; Tooze, R. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0410 Secukinumab Improves Physical Function and Quality of Life in Patients with Active Ankylosing Spondylitis: 2-Year Data from Measure 1, A Phase 3 Randomised Trial. (15th July 2016) Authors: Emery, P.; Baeten, D.; Deodhar, A.; Wei, A.; Geusens, P.; Talloczy, Z.; Gong, Y.; Porter, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. THU0126 Dose Titration of Biologics for The Treatment of Rheumatoid Arthritis and Ankylosing Spondylitis: A Systematic Literature Review. (15th July 2016) Authors: Lau, C.S.; Gibofsky, A.; Damjanov, N.; Lula, S.; Marshall, L.; Jones, H.; Emery, P. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0200 Relative effectiveness of rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis and an inadequate response to a single previous TNF inhibitor: Results from switch-RA, a global, comparative-effectiveness, observational study. (23rd January 2014) Authors: Emery, P.; Gottenberg, J.-E.; Sarzi-Puttini, P.; Moots, R.J.; Choquette, D.; Finckh, A.; Östör, A.; Andrianakos, A.; Barile-Fabris, L.; Desjuzeur, M.-L.; Hinsch-Gylvin, L.; Chung, C.; Mpofu, C. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. AB0450 Effect of adalimumab discontinuation on patient-reported outcomes and work productivity in early rheumatoid arthritis patients who achieved low disease activity following 26 weeks of treatment: Data from the optima study. (23rd January 2014) Authors: Kavanaugh, A.; Emery, P.; van Vollenhoven, R.; Cifaldi, M.; Shaw, J.; Chen, N.; Smolen, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗